Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria.
D000208:Acute Disease; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000502:Allylisopropylacetamide; D000818:Animals; D001001:Anura; D001921:Brain / Q000201:enzymology; D004594:Electrophysiology; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007082:Ileum / Q000187:drug effects; D007982:Levulinic Acids / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D009130:Muscle, Smooth / Q000187:drug effects; D009420:Nervous System / Q000473:pathology; D009469:Neuromuscular Junction / Q000187:drug effects; D011162:Porphobilinogen / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D011164:Porphyrias / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology / Q000652:urine; D011817:Rabbits
D007982:Levulinic Acids; D000502:Allylisopropylacetamide; D011162:Porphobilinogen; D000251:Adenosine Triphosphatases